tirzepatide weight loss studies for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial Semaglutide vs Tirzepatide: Which GLP-1

Given these concerns, the JDS has issued the "Recommendations for Safe Use of Incretin-Based Therapies, Second Edition" (Table 1) [13] emphasizing that careful consideration of hypoglycemia risk, remaining -cell function and mass, gastrointestinal side effects is essential when determining tirzepatide indications and treatment continuation

Le remboursement annonc le 28 mai 2026 concerne spcifiquement l'indication obsit, avec des critres d'ligibilit distincts

Providers consider which medication may best support sustainable results in conjunction with lifestyle changes

Why is there a lawsuit against Ozempic

Real Talk: Does It Work

Consulting a UK healthcare professional ensures a personalised, safe, and effective treatment plan